Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine

被引：3
|
作者：
Walter, EB [1 ]
Simmons, SS [1 ]
Bland, CL [1 ]
Clements, DA [1 ]
机构：
[1] DUKE UNIV, MED CTR, VACCINE & INFECT DIS EPIDEMIOL UNIT, DURHAM, NC USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1997年 / 16卷 / 06期
关键词：
varicella vaccine; measles-mumps-rubella-varicella vaccine; chickenpox; varicella;
D O I：
10.1097/00006454-199706000-00016
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：626 / 627
页数：2
相关论文
共 50 条
  • [1] Evaluation of a quadrivalent, measles, mumps, rubella and varicella vaccine in healthy children
    Shinefield, H
    Black, S
    Digilio, L
    Reisinger, K
    Blatter, M
    Gress, JO
    Hoffman, ML
    Eves, KA
    Klopfer, SO
    Schödel, F
    Kuter, BL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (08) : 665 - 669
  • [2] A new combined vaccine against measles, mumps, rubella and varicella in India
    Nitin Shah
    Raunak Parikh
    Giacomo Casabona
    Shafi Kolhapure
    Indian Pediatrics, 2017, 54 : 1041 - 1046
  • [3] A New Combined Vaccine Against Measles, Mumps, Rubella and Varicella in India
    Shah, Nitin
    Parikh, Raunak
    Casabona, Giacomo
    Kolhapure, Shafi
    INDIAN PEDIATRICS, 2017, 54 (12) : 1041 - 1046
  • [4] Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine
    Vázquez, M
    CURRENT OPINION IN PEDIATRICS, 2004, 16 (01) : 80 - 84
  • [5] Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Shinefield, HR
    Black, SB
    Staehle, BO
    Matthews, H
    Adelman, T
    Ensor, K
    Li, S
    Chan, I
    Heyse, J
    Waters, M
    Chan, CY
    Vessey, SJR
    Kaplan, KM
    Kuter, BJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 555 - 561
  • [6] Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad®)
    Kuter, Barbara J.
    Brown, Michelle L. Hoffman
    Hartzel, Jonathan
    Williams, Wendy R.
    Eves, Karen A.
    Black, Steve
    Shinefield, Henry
    Reisinger, Keith S.
    Marchant, Colin D.
    Sullivan, Bradley J.
    Thear, Marci
    Klopfer, Stephanie
    Xu, Jin
    Gress, Jacqueline O.
    Schoedel, Florian
    HUMAN VACCINES, 2006, 2 (05): : 205 - 214
  • [7] Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine
    Weinmann, Sheila
    Irving, Stephanie A.
    Koppolu, Padma
    Naleway, Allison L.
    Belongia, Edward A.
    Hambidge, Simon J.
    Jackson, Michael L.
    Klein, Nicola P.
    Lewin, Bruno
    Liles, Elizabeth
    Marin, Mona
    Smith, Ning
    Weintraub, Eric
    Chun, Colleen
    VACCINE, 2020, 38 (37) : 5880 - 5884
  • [8] Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children
    Knuf, M
    Habermehl, P
    Zepp, F
    Mannhardt, W
    Kuttnig, M
    Muttonen, P
    Prieler, A
    Maurer, H
    Bisanz, H
    Tornieporth, N
    Descamps, D
    Willems, P
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (01) : 12 - 18
  • [9] Measles–Mumps–Rubella–Varicella Combination Vaccine (ProQuad®): A Guide to Its Use in Children in the EU
    Lesley J. Scott
    Pediatric Drugs, 2015, 17 : 167 - 174
  • [10] Pose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children
    Shinefield, H
    Williams, WR
    Marchant, C
    Reisinger, K
    Stewart, T
    Meissner, HC
    Guerrero, J
    Klopfer, SO
    Schödel, F
    Kuter, BJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (08) : 670 - 675
12345